1Dr. Zeenath begum, 2Dr. Zoya Riyaz Syeda, 3Dr. Asra Fatima, 4Bubli Soniya Kusha, 5Qurrath Ul Ain, 6Dr. Mandakini B. Tengli, 7Nabil afnan
1,2,3,4,5,6,7Khaja Bandenawaz University- Faculty of Medical Sciences.
REFERENCES
1) Fucharoen.S, Winichagoon.P, Wisedpanichkij. R, Sae-ngow.B, Sriphanich.R, Oncoung.W. Prenatal and postnatal diagnoses of thalassemia and hemoglobinopathies by HPLC. Clinical chemistry. 1998; 44:4-740.
2) Mia, Md Babu & Sadiya, Salma & Akhter, Nilufa & Sarwardi, Golam & Banu, Bilquis & Khan, Waqar. (2015). Role of RBC Indices in Screening of Thalassaemia and other Haemoglobinopathies in Children. 31. 99-106.
3) Amani Abu-Shaheen, Humariya Heena, Abdullah Nofal, Doaa A. Abdelmoety, Abdulrahman Almatary, Mohammed Alsheef, Isamme Al Fayyad, “Epidemiology of Thalassemia in Gulf Cooperation Council Countries: A Systematic Review”, BioMed Research International, vol. 2020, Article ID 1509501, 15 pages, 2020. https://doi.org/10.1155/2020/1509501.
4) Sinha S, Black ML, Agarwal S, Colah R, Das R, Ryan K, Bellgard M, Bittles AH. Profiling βthalassaemia mutations in India at state and regional levels: implications for genetic education, screening and counselling programmes. Hugo J. 2009 Dec;3(1-4):51-62. DOI: 10.1007/ s11568-010- 9132-3. Epub 2010 Feb 10. PMID: 21119755; PMCID: PMC2882644.
5) Shivashankara A.R, Jailkhani R, Kini A. Hemoglobinopathies In Dharwad, North Karnataka: A Hospital-based Study. Journal of Clinical and Diagnostic Research [serial online] 2008 February [cited: 2008 February 4]; 2:593-599.Available from http://www.jcdr.net/back_issues.asp?issn=0973- 709x&year=2008&month= February.
6) GD, Kulkarni SS, Kadakol GS, Kulkarni BB, Kyamangoudar PH, Lakkakula BV, Thangaraj K, Shepur TA, Kulkarni ML, Gai PB. Molecular basis of β-thalassemia in Karnataka, India. Genet Test Mol Biomarkers. 2012 Feb;16(2):138-41. doi: 10.1089/gtmb.2011.0035. Epub 2011 Oct 6. PMID: 21978377.
7) Abd Rahim MR, Kho SL, Kuppusamy UR, Tan JA. Non-Invasive DNA Sampling for Molecular Analysis of Beta-Thalassemia: Amiable Alternative Sampling Methods with Accurate Results for Pediatric Patients. Clin Lab. 2015;61(9):1325-30. doi: 10.7754/clin.lab.2015.150218. PMID: 26554253.
8) Piel, F. B., Hay, S. I., Gupta, S., Weatherall, D. J., & Williams, T. N. (2017). Global burden of sickle cell anaemia in children under five, 2010–2050: Modelling based on demographics, excess mortality, and interventions. PLoS Medicine. 2017; 10(7).
9) World Health Organization (WHO).Sickle-cell anaemia: Report by the Secretariat.2006
10) Angastiniotis, M, Modell, B. Global epidemiology of hemoglobin disorders. Ann N Y Acad Sci. 1998;850(1): 251-269.
